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Abstract 
Background: Surgical dentistry during orthodontic care often occurs in adolescence and may 
involve surgical removal or exposure of teeth.  The invasive nature of treatment, combined 
with dental anxiety, means care is often provided under GA.  Best-practice guidelines however 
endorse conscious sedation as an alternative, where appropriate.  Although a limited number 
of studies have shown safe and effective use of intravenous conscious sedation (IVCS) with 
midazolam in this cohort, robust evidence to support routine its use is lacking. 
Aim: To assess whether IVCS with midazolam can effectively facilitate surgical dentistry in 
adolescent orthodontic patients in primary care. 
Method: A retrospective service evaluation was undertaken reviewing clinical records of 
adolescents (aged 12-15 years) undergoing surgical exposure and/or surgical removal of teeth 
under IVCS midazolam.   
Results: A total of 174 adolescents (mean age 14.2 years) attended for treatment between 
2009 and 2015.  Of these adolescent, 98.9% (n=172) allowed cannulation with all surgical 
dentistry completed during a single visit.  Midazolam dose ranged from 2-7mg with 79.1% 
patients having good or excellent co-operation and three minor adverse events occurring.  
Conclusion: This service evaluation shows IVCS midazolam can effectively facilitate surgical 
orthodontics in carefully selected adolescents.  There is however a distinct need to further 
explore potential for this technique to provide a viable alternative to GA. 
Introduction 
Surgical dental procedures are sometimes a necessity while patients are undergoing 
orthodontic treatment and may involve management of impacted, ectopic or supernumerary 
teeth.  Failure to address impactions, in particular maxillary canines, can result in detrimental 
effects before patients reach their mid-teens with evidence supporting adolescence as the 
optimal time to address these teeth.1, 2  Management may involve surgical removal, exposure 
or transplantation of teeth and although some adolescents accept treatment under local 
anaesthetic (LA),3 for many, anxiety and the invasive nature of treatment necessitates use of 
additional management techniques.1, 2  
Surgical removal or exposure of teeth in adolescents are recognised as ‘suitable’  justifications 
for provision of general anaesthetic (GA).4, 5   Although this technique has been shown to be 
extremely successful in facilitating such treatment in children and adolescents,2, 3 owing to 
associated risks, best-practice guidelines recommend that conscious sedation is endorsed as 
an alternative, where appropriate.4, 6, 7 
Relative analgesia (RA) nitrous oxide/oxygen inhalational sedation has proven safety and 
efficacy for children with mild to moderate anxiety and elective simple orthodontic 
extractions.7-10 Limitations are however apparent for invasive treatment9, 11 and for patients 
unable to co-operate under LA alone it appears an alternative patient management technique 
may be required.   
Midazolam has favourable properties as a sedative in that it is anxiolytic, short-acting and can 
often produce anterograde amnesia.12  In 2007, the Standing Committee on Sedation in 
Dentistry (SCSD) described the use of single-drug intravenous conscious sedation (IVCS) with 
midazolam for those aged 12 years and over in primary care as a standard sedation technique 
to facilitate dental treatment.13  More recent guidance by the Intercollegiate Advisory 
Committee for Sedation in Dentistry (IACSD),7 reiterated this sentiment with particular 
emphasis on the need for appropriate training, experience and facilities.  The use of this 
technique in adolescents has however been subject to debate, with a 2009 questionnaire sent 
to specialists in paediatric dentistry finding only 54% of respondents believing such treatment 
was appropriate in primary care.14   
IVCS with midazolam is routinely employed in adult dentistry and a small number of studies 
have shown its safe and effective use in children and adolescents to facilitate a variety of 
dental procedures, including surgical dentistry.12, 15-18  In 2003, a randomised controlled cross-
over trial by Wilson et al.12 demonstrated IVCS with midazolam to be a safe, effective and 
well-accepted alternative to RA sedation for 12-16 year olds requiring simple orthodontic 
extractions.  The same year, a small retrospective study by Robb et al.17 demonstrated 
successful and safe IVCS with midazolam in eighteen 11-15 year olds receiving wide-ranging 
treatment with good patient co-operation and willingness to receive IVCS at subsequent visits 
suggesting adolescent acceptance of this technique.  
In 2007, Dorman et al.19 published a retrospective case review of 28 patients aged between 
11 and 15 years who underwent surgical orthodontic treatment under IVCS with midazolam.  
A broad range of procedures were provided (often multiple teeth during each visit) by a 
suitably trained, experienced and equipped non-anaesthetist operator-sedationist, with 89% 
of patients completing treatment as planned.  Owing to the small number of subjects firm 
conclusions cannot be drawn, this study however provides foundations upon which to build 
further research whilst also highlighting potential limitations of this technique.   
Although there is a large body of literature reporting surgical orthodontic procedures, this 
largely focuses on surgical and orthodontic outcomes and can fail to document the method 
used to facilitate treatment.2  This limits ability to accurately identify current practice with 
regard to different behavioural management techniques and evidence to inform decision-
making in anaesthetic choice is lacking.9, 20, 21  
In summary, there is currently a lack of robust evidence demonstrating effective use of IVCS 
with midazolam in adolescents.  Despite published recommendations supporting the use of 
this sedation modality in this cohort, there is a lack of evidence to support its routine use in 
primary care.  This service evaluation will attempt to add to the evidence base for use of IVCS 
with midazolam in adolescents. 
Aim 
To assess whether IVCS with midazolam, in combination with local anaesthesia, can be 
employed effectively as a behavioural management tool to facilitate surgical dental treatment 
in adolescent orthodontic patients in primary care. 
Methods 
A retrospective service evaluation was undertaken based on review of computer and paper-
based clinical records at Queensway Teesside Oral Surgery Service (QTOSS).  QTOSS is a 
primary care-based NHS specialist oral surgery referral service offering IVCS with midazolam 
to facilitate surgical dentistry for adolescents as part of orthodontic treatment.   
In this service, all participants adhered to the following pathway: 
Patient Assessment 
Patients were assessed on a separate day to treatment by one Specialist Oral Surgeon holding 
a Diploma in Conscious Sedation (MD) with planned treatment being confirmed following 
appropriate patient examination.  Formal assessment of dental anxiety was made using an in-
house dental anxiety questionnaire (first 25 patients) or Modified Dental Anxiety Scale 
(MDAS)22 (subsequent 149 patients - MDAS was only introduced in the practice after the first 
25 patients).  Vital signs were recorded (blood pressure, oxygen saturation, heart rate), body 
mass index (BMI) calculated and American Society of Anesthesiologists23 (ASA) physical 
classification system score assigned to determine fitness to receive sedation in primary care. 
Assessment of physical and psychological aptitude to undergo treatment under IVCS with 
midazolam was made and management options explained; including their risks and benefits.  
These included non-pharmacological behavioural management plus care under: 
 LA alone 
 RA sedation and LA 
 IVCS with midazolam (including cannulation) and LA 
The option of treatment under GA was also discussed, with patients opting for GA discharged 
to their referring practitioner to consider referral to secondary care.  Adolescents played a 
key role in the consent process and for those proceeding with care, informed written consent 
was gained from a legal guardian with additional adolescent consent/assent as appropriate.  
Clear pre- and post-sedation instructions were given verbally and in written form including a 
request for patients to starve for two hours prior to treatment. 
Patient Treatment 
The operator-sedationist providing treatment (MD) was assisted by two sedation-qualified 
dental nurses.  Baseline vital signs were recorded and venous cannulation achieved in the 
dorsum of the hand or antecubital fossa.  Midazolam was titrated in 1mg/minute increments 
with continuous assessment of patient response to sedation by the operator-sedationist.  In 
some cases the decision was made to provide final increments at 0.5mg/minute (individual 
dependent), until the patient was happy to begin treatment and deemed optimally sedated.  
The option was given to escorts to be present during treatment, with patient consent.   
Patients were continuously monitored visually during treatment to assess level of sedation 
and co-operation, using descriptors detailed in Tables 1 and 2, respectively.  Continual pulse 
oximetry was undertaken and blood pressure measured pre- and post-sedation and at 
appropriate intervals during treatment.  In recovery, patients were monitored by a sedation-
trained dental nurse and fitness for discharge assessed at least 1 hour after the last increment 
of midazolam.   
Level of Sedation 
Score Description 
1 Fully awake and orientated 
2 Drowsy 
3 Eyes closed but rousable to command 
4 Eyes closed but rousable to mild physical stimulation (earlobe tug) 
5 Eyes closed but unrousable to mild physical stimulation 
Table 1.  Descriptors of patient level of sedation - ‘Wilson Scores’24   Reproduced with permission from 
E Wilson et al., ‘Sedation during spinal anaesthesia: comparison of propofol and midazolam’, Br J 
Anaesth 1990; 64: 1, by permission of Oxford University Press   
Level of Co-operation 
Rating Description 
Excellent Patient fully co-operative, all treatment completed 
Good 
Minimal interference from patient, (for example, crying with cannulation 
or local anaesthetic), all treatment completed 
Fair 
Some patient disruption during treatment or additional management 
steps required to facilitate treatment (for example, mouth prop).  All 
treatment eventually completed. 
Poor 
Patient very disruptive during treatment making provision of care very 
difficult/impossible 
Table 2.   Descriptors of patient co-operation 
Patient Sample 
Criteria used to identify adolescents for the evaluation are detailed below:  
Inclusion Criteria: 
 Patients aged 12 years and over but less than 16 years of age 
 At least one tooth requiring surgical removal or exposure 
 Treatment performed under IVCS with midazolam and LA 
Exclusion Criteria: 
 Patients aged less than 12 years or 16 years and over 
 No teeth requiring surgical removal or exposure 
 Treatment not performed under IVCS with midazolam and LA 
Data Collection 
A consecutive sample of clinical records was reviewed for adolescents meeting the inclusion 
criteria between December 2009 and December 2015.  Information collected included: 
patient demographics and details of sedation provided, treatment performed, sedation or 
treatment-related complications or adverse events, and any additional procedural comments. 
Data were entered into a Microsoft Excel spreadsheet.   
Sedation-related complications or adverse events were noted with reference to the World 
SIVA Adverse Sedation Event Reporting Tool25 and additional complications commonly 
reported in the literature (Table 3).18  The severity of such events was categorised into either 
mild, moderate or severe using the approach reported by Wilson et al.26 
Sedation-related Complications 
Severity Description 
Mild  Managed in clinic 
 Treatment completed 
 Patient discharged home 
For example: nausea, vomiting, faint, transient oxygen desaturation 
SaO2 ≤90% corrected with verbal stimulus/supplemental oxygen, 
paradoxical response, minor/transient changes to vital signs 
Moderate  Managed in clinic 
 Treatment completed 
 Prolonged recovery/medical advice sought 
 Patient discharged home 
For example: allergic reaction without anaphylaxis, more pronounced 
change to vital signs, over-sedation requiring reversal 
Severe  Treatment stopped 
 Medical intervention required 
 Patient admitted to hospital 
For example: respiratory depression with oxygen desaturation 
prolonged or SaO2 <75%, airway obstruction, aspiration, laryngospasm, 
bronchospasm, allergic reaction with anaphylaxis, loss of consciousness 
 
Table 3.  Sedation-related complications categorised by severity 
 
Ethical Considerations 
Ethical approval was not required for this service evaluation.   
Data Analysis 
Data were analysed and results are presented as descriptive statistics.   
Results 
Patient Demographics 
One hundred and seventy four patients attended appointments for surgical orthodontic 
treatment under IVCS with midazolam.  Patients were ASA I (n=129) or ASA II (n=45) with a 
mean BMI of 21.0 (range 15.0-31.0).  Figure 1 shows the distribution of patient age ranging 
from 12.1 to 15.9 years (mean 14.2 years, standard deviation (SD) 0.96).  One hundred and 
fourteen patients were female and sixty male (mean ages 14.3 years and 14.1 years, 
respectively).    
 
Figure 1.  Age and gender of adolescents attending for treatment 
One hundred and forty nine adolescents completed MDAS questionnaires with Figure 2 
showing their self-perceived anxiety towards dental treatment.  This was seen to be wide-
ranging and skewed to the lower end of the anxiety spectrum with a median of 13/25.   
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 Figure 2.  Reported anxiety of adolescents attending for treatment under IVCS with midazolam 
Acceptance of Cannulation 
Two patients (1.1%) did not permit any attempt at cannulation and were discharged for 
onward referral for treatment under GA.  Of the remaining 172 patients, all were cannulated 
successfully (94.2% on the first attempt) with no more than 2 cannulation attempts being 
required.   Cannulation adjuncts, provided only on patient request, were employed in 39 
adolescents (Table 4).   If requested the following options were available: topical ethyl 
chloride spray, topical Eutectic Mixture of Local Anaesthetic (EMLA) or RA sedation.   
 
 
 
 
Table 4.  Adjuncts used to assist with cannulation 
Cannulation adjunct 
Number of 
patients 
Total 
None 133 
172 
Ethyl chloride spray 32 
Eutectic Mixture of Local Anaesthetic (EMLA) 4 
Nitrous oxide/oxygen 3 
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Midazolam Dose 
The dose of midazolam administered ranged from 2-7mg (Figure 3) with median and mode 
dosages being 4.0mg and 5.0mg for each gender and the cohort as a whole.  
 
Figure 3.  Dose of midazolam administered 
Level of Sedation 
Throughout treatment and recovery all patients except one were responsive to verbal stimuli 
(Wilson Scores 1-3).  One patient was initially only responsive to light tactile stimuli (Wilson 
Score 4) after the last midazolam increment (5mg in total).  As vital signs were normal, the 
decision was made to proceed with treatment and after 5 minutes the patient became 
responsive to verbal stimuli. 
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Patient Co-operation 
Once sedated, all 172 adolescents were happy to proceed with treatment with Table 5 
showing patient co-operation.   77.9% males and 79.7% females had good or excellent co-
operation with that of the cohort as a whole being 79.1%.  Twenty eight patients (16.3%) were 
noted as being very nervous or teary on cannulation, exhibiting anxiety related to this aspect 
of care, once sedated, 19 (67.9%) settled well and had good or excellent co-operation.  
 
 
 
 
 
 
 
Table 5.  Patient co-operation during treatment 
A number of factors made provision of treatment more challenging.  There were fifteen 
instances of tears during treatment, eight of increased head movement, ten of reduced 
mouth opening and five reports of the patient being talkative.  Some patients exhibited more 
than one of these behaviours.  In addition to this, one patient had a profound gag reflex.   
Adverse Events 
During treatment, for all patients, physiological parameters remained within normal limits.  
As previously noted, for a period of time, one adolescent exhibited a lower level of 
responsiveness than required under the definition of conscious sedation.  In recovery 
following treatment, one patient was verbally abusive to staff and another was tearful, both 
potential examples of recovery agitation.  Clinical records reported both patients had been a 
little teary during treatment but all surgery was completed without difficulty.  These 3 events 
give an overall adverse event rate of 1.7% 
 
 
Patient Co-operation 
Excellent Good Fair Poor 
Number 
of 
patients 
Male 
(% all males) 
10 
 (16.9%) 
36  
(61%) 
9  
(15.3%) 
4 
 (6.8%) 
Female  
(% all females) 
7 
(6.2%) 
83 
(73.5%) 
19 
(16.8%) 
4 
(3.5%) 
Total 
(% cohort) 
17  
(9.9%) 
119  
(69.2%) 
28  
(16.3%) 
8  
(4.6%) 
Dental Treatment Provided 
For all sedated patients, all planned dental treatment was completed successfully in a single 
visit. The median time taken in surgery for sedation and treatment was 45 minutes 
(interquartile range 39 - 55 minutes).  Patients received at least one of the following four 
procedures: 
 surgical canine exposure 
 surgical exposure of another permanent tooth  
 surgical removal of a primary tooth 
 surgical removal of a permanent tooth 
 
The number of teeth undergoing surgical treatment per patient ranged from 1 to 4 (mean = 
1) with eight patients undergoing surgical exposure and surgical removal of teeth during the 
same visit.  75.6% procedures required bone removal.  For 93 patients, treatment was 
performed in combination with other less complex additional procedures such as simple 
extraction of deciduous and/or permanent teeth (Table 6).  The most common procedure was 
canine exposure (66.9% patients with 45% buccal and 55% palatal) with 79% requiring bone 
removal. 
Procedure 
Number of 
teeth 
Number of 
patients 
% Patients 
Primary Procedure(s) 
Surgical removal of deciduous tooth/teeth 2 2 1.2% 
Surgical removal of permanent tooth/teeth 52 47 27.3% 
Canine exposure(s) 134 115 66.9% 
Other permanent tooth exposure(s) 21 16 9.3% 
Additional/secondary Procedures 
Simple deciduous tooth extraction(s)  80 55 32.0% 
Simple permanent tooth extraction(s) 106 52 30.2% 
Table 6.  Summary of treatment provided (note: some patients received multiple procedures in 
terms of both volume and type)  
Surgical Treatment Complications 
Three patients required further treatment for re-exposures (four teeth) giving a re-exposure 
rate of 2.3% of patients (2.6% teeth).  More detailed review of records showed the need for 
re-exposure being the result of gold chain de-bond (two upper canines in one patient, one 
lower premolar in another patient) and mucosal overgrowth (of a palatally exposed canine in 
one patient).  Considering the most commonly performed procedure, canine exposure; the 
re-exposure rate was 2.3% of canines (1.8% patients).  
Discussion 
The age group studied was designed to reflect ‘adolescence’, with twelve years chosen as a 
minimal age in-line with SCSD and IACSD guidance.7, 13    Patient age was wide-ranging but 
skewed to the older end of the spectrum; similar to findings of others.16, 19  This could be 
explained by older patients having the greater maturity required to accept care under IVCS or 
perhaps some explanation lies with the time at which orthodontic and/or oral surgery 
treatment begins. Approximately two thirds of patients were female.  Recognised gender 
differences such as; rate of impaction,27 perceived maturity during adolescence and 
motivation for treatment may play a role in this trend however the potential for referral 
tendencies of orthodontists to influence patient characteristics must be remembered.  
Male anxiety was skewed to the lower end of the MDAS spectrum and of those deemed to 
have ‘high anxiety’ (MDAS 19-25),22 females had greater representation suggesting females 
are more anxious than males, or perhaps more prepared to admit it. This trend has been 
noted in young adults and adolescents and could lead to greater proportions of females opting 
for treatment under sedation or GA.22, 28, 29   
Although MDAS has been employed in adolescents aged 12 years and over, as a means of 
assessing dental anxiety,28, 30 cut-off scores for sedation-need are based on research with 
adult populations and its use in adolescents must be carefully considered.  Using MDAS, 
twenty-three patients (15.4%) were deemed to be highly dentally anxious, greater than that 
reported by the Children’s Dental Health Survey in 2013 (14% of 12 year olds and 10% of 15 
year olds).28  This could be explained by high female representation in the cohort however 
MDAS does not assess anxiety in relation to oral surgery procedures; likely to be at the 
forefront of the minds of this cohort.   
IVCS midazolam was employed in this patient group, despite many being deemed to have ‘low 
anxiety’ using MDAS.  The Indicator of Sedation Need (IOSN) attempts to objectively assess 
sedation need and addresses failure of MDAS to appreciate the impact of medical history and 
treatment complexity on patient management.31 Although IOSN has been reported as useful 
to sedation decision-making in adults,32  Gerrard33 recently questioned its validity and 
reliability in defining sedation need in adults undergoing oral surgery procedures.  Even in 
adult populations, with evidence supporting the safe and effective use of IVCS with 
midazolam, decision-making in relation to sedation provision is not always clear and evidence 
is lacking for appropriate management of adolescents.  It is however clear anxiety should not 
be used as the sole means of determining sedation need.   
What is of interest is that 77% of patients were cannulated without the use of cannulation 
adjuncts.  Although shown not to guarantee cannulation acceptance, they may reduce anxiety 
and cannulation did pose a significant barrier to care for some patients, confirming findings 
of others.10, 15  In such cases the potential for gaseous induction of GA has a clear advantage 
over a sedation modality relying on the IV route.  GA is a highly effective behavioural 
management tool and will always have a role in facilitating dental care for some patients.   
Paediatric morbidity and mortality have occurred using techniques and drugs out-with the 
strict United Kingdom (UK) regulation of dental conscious sedation;6, 18, 20 raising concerns 
about sedation safety.  Although there has been limited research in children and adolescents 
within dentistry in the UK, the National Institute for Health and Care Excellence has reported 
midazolam as a sole-agent used in children in dentistry and other medical specialities to have 
a “good” safety profile.20  This evaluation showed effective use of IVCS with midazolam in a 
primary care environment with very few adverse events, all of which were minor.  The patient 
in this case series initially unresponsive to verbal stimuli was slightly over-sedated, 
demonstrating the need for careful titration.   
A wide-range and volume of surgical dentistry was provided under IVCS with midazolam for 
carefully selected patients in an effective manner with the canine re-exposure rate comparing 
favourably with those of GA34, 35 and Dorman et al,19 suggesting high quality care.  The time 
taken to provide treatment (sedation and surgery) was longer than that cited for similar 
procedures under GA.36 Such reports however tend to cite surgical time only, without 
anaesthetic induction or recovery.  Treatment under IVCS with midazolam in primary care by 
a non-anaesthetist sedationist is considerably less costly than under GA in a secondary care 
setting.20  With success rates seen in this study, provision of care under IVCS with midazolam 
has the potential to save NHS resources, increase access to care at local clinics and free-up 
hospital services.37, 38  
Limitations and Further Research 
This evaluation describes only one cohort undergoing surgical orthodontic treatment with 
midazolam IVCS and the trends seen in patient characteristics cannot be considered stead-
fast indicators of suitability to undergo such care.  It is clear a number of factors acting in 
unison impact on adolescent suitability for and acceptance of this treatment modality and 
more robust research is required to aid decision-making regarding behavioural management 
techniques.  Although Germain et al.36 found surgeons could not accurately predict difficulty 
of exposure of palatal maxillary canines using radiographic findings alone, quantification of 
the invasiveness of treatment undertaken in this service evaluation would have been 
advantageous.   
Although a number of behavioural management techniques were offered, there is potential 
for referring and treating clinician preference or bias to influence characteristics of patients 
assessed and attending for care.  Additionally, the impact of service facilities, location and 
contract may influence the patient cohort and forms of behavioural management available.  
Although this evaluation showed a suitably qualified team, led by one highly experienced 
operator-sedationist, could provide effective adolescent care under IVCS with midazolam, 
there is a distinct need for other dental teams to reproduce this success through prospective 
study.   
Sub-optimal co-operation can negatively impact provision of care in both adults and 
children.16, 19, 26  Disruptive behaviour exhibited by adolescents could be explained by 
paradoxical reaction, disinhibition or similar phenomena and characterised as adverse events.  
Assessment to ensure suitability and preparation for sedation can reduce incidence of such 
occurrences, with recognition that physiological and psychological maturity can vary widely 
in adolescents of a similar age.  Owing to the retrospective nature of this study it is not 
possible to deduce the exact cause of behavioural traits displayed and although co-operation 
was recorded prospectively, this was not using a validated scale.  A system such as the Houpt 
Scale39 would enable more reliable behavioural assessment and standardisation of adverse 
incident reporting should enable robust assessment of sedation safety.18, 25 
Almost 80% patients exhibited excellent or good co-operation, with relaxation of those highly 
anxious prior to treatment demonstrating the role of anxiolysis in facilitating care.  Although 
treatment success was high in those attending for elective orthodontic procedures, its 
relevance to those receiving urgent dental care or with dental decay and sepsis must be 
carefully considered and could explain lower success rates seen by Averley et al.15  With some 
patients noted to be tearful during treatment, there is a distinct need to ensure this sedation 
technique provides sufficient anxiolysis.  The three patients requiring re-exposures opted for 
treatment under LA alone or in combination with IVCS midazolam at the second visit, 
suggesting good acceptance of this technique.  Assessment of adolescent experience through 
qualitative study would provide evidence relating to patient-perceived acceptability of IVCS 
with midazolam. 
Retrospective review of records has potential to reduce accuracy of results obtained. 16  Well-
designed prospective studies providing surgical orthodontics using techniques across the 
behavioural management spectrum, not just IVCS midazolam and GA, with subsequent 
evaluation of safety and success, would allow comparison of different techniques.  A 
Cochrane systematic review identified randomised allocation would allow assessment of IVCS 
as an alternative to GA; ethical dilemmas posed by doing so are however clear with inability 
to blind operators to technique used likely to limit the strength of evidence directly comparing 
these techniques.21    
Conclusion 
This service evaluation has shown IVCS with midazolam, in combination with effective LA, can 
successfully facilitate surgical orthodontic treatment in carefully selected adolescents in 
primary care.  This supports the appropriate use of this technique by suitably trained, 
experienced and equipped teams to facilitate not only surgical orthodontic treatment but also 
less complex dental procedures.   
There is a distinct need to further explore the potential of this technique to provide a safe 
and effective alternative to GA and benefit a significant proportion of adolescent patients, 
particularly those undergoing elective orthodontic procedures.  
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